CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.
Media Contact: [email protected]
California Life Sciences Announces Winners of 21st Annual Pantheon Awards
Nov 8, 2024
Celebrating the Trailblazers Advancing California’s Life Sciences Industry FOR IMMEDIATE RELEASE: Nov 8, 2024 SAN FRANCISCO, Calif, — California Life Sciences (CLS) is thrilled to announce the winners of its..
Read MoreCelebrating Innovation: Public Voting Now Open for California Life Sciences’ 21st Annual Pantheon Awards
Oct 1, 2024
FOR IMMEDIATE RELEASE: Oct 1, 2024 SAN FRANCISCO, Calif, — California Life Sciences (CLS), the state’s leading life sciences membership organization, announced today the finalists for the 2024 Pantheon Awards. The..
Read MoreFAST Fall 2024 Cohort Announced
Sep 23, 2024
A dozen life sciences startups have been selected to receive 12 weeks of business mentoring from expert advisors through California Life Sciences’ advisory program, FAST California. Now in its eleventh..
Read MoreCLS has Partnered with San Diego Squared (SD2)
Sep 4, 2024
CLS has partnered with San Diego Squared (SD2) to support its mission to empower historically marginalized and underserved high school and college students who have demonstrated talent in a STEM field...
Read MoreCalifornia Life Sciences Announces Five New Board Members
Aug 19, 2024
San Francisco, CA – California Life Sciences (CLS), the state’s most impactful life sciences membership organization advocating for the sector and its diverse innovation pipeline, today announced five new board members..
Read MoreStatement from CLS CEO, Mike Guerra, on CMS Drug Pricing
Aug 15, 2024
Following the conclusion of an arbitrary process, CMS has released the drug prices for the first ten products selected for the Medicare Drug Price Negotiation Program with cuts to list..
Read More

